Left ventricular (LV) diastolic dysfunction may lead to heart failure. A high body mass index (BMI) is associated with worse LV diastolic function. However, knowledge of the longitudinal relation between changes in BMI and LV diastolic function is limited. 
Methods and results
We retrospectively identified 165 asymptomatic individuals (aged 60 ± 10 years, 55% male) with preserved LV ejection fraction, who underwent repeated health check-ups (median interval: 365 days) at our hospital between 2009 and 2012. The longitudinal data were analysed using a linear mixed-effects model adjusted for important clinical variables at baseline to evaluate the associations between changes in BMI and LV diastolic function from one visit to the next. Baseline characteristics were BMI, 23 ± 3 kg/m 2 ; E/E 0 ratio, 9 ± 2; E 0 velocity, 8 ± 2 cm/s; and left atrial (LA) volume index, 26 ± 8 mL/m 2 . Eighty-two of our participants had baseline LV diastolic dysfunction. In multivariable analyses, a BMI change was associated with a change in LV diastolic function. A one-unit decrease in BMI between consecutive visits corresponded to an average decrease in LA volume index of 0.80 mL/m 2 (95% confidence interval: 0.38, 1.23 ; P < 0.001), a decrease in E/E 0 ratio of 0.11 (-0.015, 0.23; P = 0.086), and an increase in E 0 velocity of 0.11 cm/s (0.18, 0.031; P = 0.006). 
Introduction
Left ventricular (LV) diastolic dysfunction is an independent predictor of future cardiovascular events including stroke, atrial fibrillation, congestive heart failure (HF), and death. [1] [2] [3] [4] As there is no convincing treatment for LV diastolic dysfunction, prevention of worsening LV diastolic function is of utmost importance. Previous studies investigating severely obese subjects consistently demonstrated that intentional weight loss improves cardiac function including diastolic function. [5] [6] [7] [8] [9] Furthermore, cross-sectional studies demonstrated that a high body mass index (BMI) was associated with worse LV diastolic function. 10, 11 However, a longitudinal relation between changes in weight and LV diastolic function over time in the general population is still unclear, since serial echocardiographic data from the general population are very limited. 12 We hypothesized that BMI reduction may have a beneficial effect on LV diastolic function in the general population. Hence, we investigated the impact of a change in BMI on LV diastolic function in individuals using longitudinal data from the health check-up clinic at the University of Tokyo Hospital, Tokyo, Japan.
Methods
This study was approved by the institutional ethics committee of the University of Tokyo.
Ningen Dock health data: a longitudinal study
We retrospectively obtained longitudinal data in 228 adults who underwent repeated echocardiography in the health check-up clinic at the University of Tokyo Hospital between July 2009 and July 2012. Our clinic provides a health check-up for the promotion of health through voluntary medical examinations; the systems, called 'Ningen Dock', are very popular in Japan. [13] [14] [15] Indeed, according to the data from 2010 Census in Japan, 16 almost 65% of adults in Japan (men 69.4% and women 59.7%) underwent similar health check-ups. Our echo laboratory is maintained under the guidelines of the Japanese Society of Echocardiography. 17 The exclusion criteria included the following: a prior or current history of heart valve disease, HF or myocardial infarction, an LV ejection fraction (LVEF) < 45%, LV regional wall motion abnormalities, atrial fibrillation, and poor echocardiographic images. We chose LVEF > _45% for the study population, because a previous study showed LVEF does not further contribute to outcome once it is above 45%. 18 We also excluded symptomatic patients who could not tolerate the position during the examination of the echocardiography. We reviewed echocardiographic images from the apical windows in all cases to make sure that they were adequate for measuring left atrial (LA) volume. Our final analysis included 165 persons who had a total of 422 echocardiographic studies. We obtained information regarding gender, birth date, lifestyle, and medical history of each person through a self-administered questionnaire and confirmed the information through an interview with a physician. We measured blood pressure (BP) twice using an automatic device after several minutes of rest in a seated position. Individuals on hypertensive medication or with a BP >140/90 mmHg were categorized as having hypertension. Individuals on diabetic medication or with a haemoglobin A1C > 6.5% were categorized as having diabetes. Prior or current valvular disease or old myocardial infarction was identified through a self-administered questionnaire. We measured the body height and weight of all individuals during hospital visits, and BMI was calculated. We adopted the international classification of adults 19 
Echocardiographic imaging
We performed echocardiography to screen for valvular stenosis or regurgitation using Toshiba Xario or Aplio (Toshiba Medical Systems Corp, Tochigi, Japan). We excluded individuals with significant regurgitation or stenosis from the analysis, since valve disease has a strong influence on LA volume. Quantification of LV and LA chamber parameters was performed with 2D echocardiography. LV systolic function was assessed by LVEF using the Teichholz formula in accordance with published guidelines. 12 LV mass was calculated using diastolic measurements of LV internal diameter and wall thickness on 2D echocardiography according to the formula recommended by the American Society of Echocardiography: LV mass (g) = 0.8
3 ]}BMI þ 6 g (IVST, interventricular septal wall thickness; LVID, LV internal diameter; and PWT, posterior wall thickness). 20 LV mass index was calculated as LV mass/body surface area. LA volume was measured by the study investigators (T.N. and M.H.) using the biplane area-length method in accordance with the guidelines. 12 Then, LA volume index was calculated as LA volume/body surface area. We evaluated diastolic dysfunction as previously described 10,21 using transmitral diastolic flow by pulsed-wave Doppler from an apical fourchamber view and pulsed tissue Doppler imaging (TDI) of LV myocardial velocities. Peak velocities of the early (E-wave) and late (A-wave) phase of the mitral inflow pattern from pulsed-wave Doppler recordings were measured, and their ratio (E/A) was calculated. We measured the peak early diastolic (E 0 ) velocities of the septal mitral annulus by pulsed TDI. We calculated the ratio between the E and the E 0 wave (E/E 0 ) as an index of LV filling pressure. Diastolic function was classified as normal or abnormal, and then diastolic dysfunction (when it was present) was assigned following the guideline. 21 To estimate inter-and intra-reader variability, two independent observers performed echocardiographic measurements of LV mass index, LA volume index, and E/E 0 in randomly selected 10 subjects and one observer repeated the measurements subsequently. The inter-and intra-observer variability was estimated using an intra-class correlation coefficient 
Variable selection
We investigated the association between changes in BMI and LV diastolic function. LA volume index, E 0 velocity, and E/E' ratio was used as markers of LV diastolic function, and these parameters were cross-sectionally shown to be associated with increased BMI. 1, 10, 11 These outcome variables, as well as BMI, were repeatedly measured at each Ningen Dock. Baseline independent variables were measured at the initial clinic visit. We adjusted for gender and age at the initial clinic visit. We also adjusted for the initial measure of LV diastolic dysfunction grade. In addition, we included the following baseline variables that showed significant associations with LV diastolic function indices in previous cross-sectional studies 10, 11, 22, 23 : BMI, systolic BP, presence of diabetes, haemoglobin, heart rate, and LV mass index.
Statistical methods
The population used in the analysis included all individuals who had multiple Ningen Dock visits throughout the study period. A preliminary study on the changes in clinical variables between the initial and last visits was performed to determine whether the Wilcoxon signed-rank test or Bowker's test should be used. Since the data contained possibly correlated repeated measurements and different numbers of visits, a linear mixed-effects model was used to evaluate the association between outcome and BMI. The linear mixed-effects model consisted of two components, a random effects component that represented individual-specific contributions and a fixed-effects component that was constant across individuals. In our data set, we included BMI as a random effect, since it varied from visit to visit and from individual to individual. We also included a
random intercept to account for high variation in BMI. To adjust for influential factors such as gender and age, we included these measurements at the baseline visit as fixed effects. Additional potential fixed-effect variables included the presence or absence of diabetes, systolic BP, haemoglobin, LV mass index, and LV diastolic function grade. The interpretation of the mixed-effects model is similar to that of traditional linear regression, but the former provides a more in-depth explanation; the random-effect parameters (random intercept and slope) represent the general variability among individuals, whereas the fixed-effect parameters (fixed intercept and slope) provide insight into the population variability. The mixedeffects model was fitted for each of the three outcome variables: LA volume index, E/E 0 ratio, and E 0 velocity. A forward variable selection with Akaike's information criterion (AIC) was performed in search of the best model. We started from a simple model that included the main covariates of interest (BMI, gender, and age) and then added other potential covariates (systolic BP, diabetes, haemoglobin, heart rate, LV mass index, and LV diastolic function at the baseline visit). Estimates and the corresponding 95% CIs were reported for the slope of BMI and the fixed effects of the baseline independent variables. The statistical tests were performed using a two-sided significance level of 0.05. The baseline characteristics were summarized with continuous variables presented as mean ± standard deviation, and categorical variables presented as counts and percentages. All analyses were performed using commercially available software (SAS, version 9.4 for Windows; and R, version 3.2.3).
Results
Baseline characteristics of participants Table 1 summarizes the baseline characteristics of the 165 study individuals (55% male) and 422 echocardiographic studies that met the selection criterion. Among the study population, all but one participant had LVEF more than 55%; the one had LVEF of 52%. At the initial visits, 27% were identified to have hypertension, 73% had normal BMI, and almost half of the individuals had LV diastolic dysfunction. The number of visits was not evenly distributed, since the majority of individuals had two (48%) or three (50%) visits. The mean interval between two consecutive visits was 379 days with an SD of 94 days, and the median interval was 365 days. Throughout the study, most individuals showed BMI changes between consecutive visits, and the range of the change in BMI was -4.3 to 3.5 kg/m 2 . Although all individuals enrolled in the study claimed to be asymptomatic, four were categorized as having severe diastolic dysfunction.
Relation between changes in BMI and LV diastolic function indices Table 2 summarizes the important clinical variables at the baseline visit and the last visit. The distribution of BMI values did not change significantly between the baseline and last visits. The median time interval between two consecutive visits was 365 days. To investigate the relation between changes in BMI and LV diastolic function, we used the mixed-effects model, which revealed statistically significant associations between changes in LV diastolic function indices and BMI (Table 3) . Concretely, a one-unit increase in BMI corresponded to an average increase in LA volume index of 0.80 mL/m 2 (P < 0.001) and a decrease in E 0 velocity of 0.11 cm/s (P = 0.006). Furthermore, there was a trend for an association between an increase in BMI and E/E 0 ratio; a one-unit increase in BMI corresponded to a 0.11 increase in E/E 0 ratio (P = 0.086). The directions of associations were confirmed in Figure 1 , which displayed the fitted regression lines adjusted for variables other than BMI at both the population level (black line) and individual level (grey lines). In addition, age and gender appeared to be positively associated with E/E 0 ratio (P < 0.001 for both age and gender) and negatively associated with E 0 velocity (P < 0.001 for age and P = 0.015 for gender). Both systolic BP and presence of diabetes were significantly associated with E/E 0 ratio and E 0 velocity.
Moreover, LV diastolic dysfunction, but not normal diastolic function, was significantly associated with all indices of LV diastolic function (LA volume index, E/E 0 ratio, and E 0 velocity).
Discussion
We examined the association between changes in BMI and LV diastolic function in longitudinal data using a linear mixed-effects model, which accounted for within-person random effects. Since participants 
did not experience height changes, the BMI change was due to a weight change. The most important result of our analysis was the association between LV diastolic function and weight change. In particular, a BMI decrease was significantly associated with improved LV diastolic function as measured by LA volume index and E 0 velocity. In spite of a non-significant association between an increase in BMI and E/E 0 ratio, a one-unit increase in BMI corresponded to a 0.11 increase in E/E 0 ratio.
Furthermore, the observed changes in diastolic parameters following BMI reduction in this study were found in participants who were mainly within the normal BMI range and had normal or mildly impaired diastolic function. In contrast, previous studies [5] [6] [7] [8] [9] 24 were done in individuals with very high BMI or severely impaired diastolic function. Our findings showed that even in subjects with a normal BMI or echo parameters, there was a significant association between changes in weight and LV diastolic function. These findings may be more relevant to a general population than the findings of previous studies, since previous studies targeted obese individuals or those with severe diastolic dysfunction.
Previous reports showed that a large BMI is associated with worse LV diastolic function. 10 However, weight change and its influence on LV diastolic function have not been investigated fully, since there are few studies in which serial echocardiography was performed in the general population. Our results confirm and expand upon the results of previous studies. 5, 24 The number of subjects in our study (n = 165)
is much larger than that in a previous study (n = 25) from the 1990s, which showed that weight reduction was associated with improved LV diastolic filling. 5 Furthermore, the evaluation of LV diastolic function has evolved since then 21 and that earlier study did not measure E 0 velocity, E/E 0 ratio, or LA volume index. 5 In addition, we used multivariable analysis to try to account for all possible variables that might have influenced LV diastolic function in our population. Although a previous study showed that weight reduction was associated with improved E 0 velocity in univariate analysis, 24 a high prevalence of hypertension (35%) and diabetes (36%) in their population may have limited the generalizability of their results, as these co-morbidities influence LV diastolic function. 22 Finally, our results on the association between LV diastolic function and the examined covariates are in accordance with previous findings from cross-sectional studies.
For instance, age was significantly associated with E/E 0 ratio and E 0 velocity but not with LA volume index. 11, 25, 26 In addition, female gender was significantly associated with worse LV diastolic function, 26 and diabetes and systolic BP were significantly associated with E/E 0 ratio and E 0 velocity. 22 Our results are also in accordance with data from animal studies. 27, 28 Originally, the association between weight loss and improved LV diastolic function was discovered in the context of ageing and calorie restriction, because ageing is known to be associated with deteriorated LV diastolic function. 25, 26 A pioneering study using mice demonstrated that weight loss by calorie restriction was associated with improved LV diastolic function. 27 Recently, the association between weight loss achieved by calorie restriction and improved LV diastolic function was confirmed. 28 Furthermore, the pathological analysis of mice hearts after caloric restriction showed that improved intracellular calcium ion handling was associated with improved LV diastolic function. 28 BMI is not an ideal anthropometric measure of body fat. Indeed, given the same BMI, the relative composition of fat mass and lean body seems to depend on age and gender. 29 A previous report from community cohort showed waist-to-hip ratio had a stronger correlation with LV dysfunction and mortality than BMI. 30 Another investigation from a community cohort also showed that visceral fat measured by computer tomography imaging was independently associated with LV geometry and function. 31 However, given that all our participants are East Asian, BMI may be an acceptable surrogate measure in our population, because race/ethnicity impacts its correlation with anthropometric measures and adipose tissue as well. 29 Indeed, the analysis of the Chinese subgroup in the INTERHEART study, 32 a global case-control study of risk factors for acute myocardial infarction, showed BMI was a good predictor for myocardial infarction risk, along with waist circumference and waist-to-hip ratio. Prevention of diastolic HF is of the utmost importance, because there is no established therapy for diastolic dysfunction. A crosssectional study showed associations between high BMI and worse LV diastolic function indices. 10 Although major weight loss among severe obese subjects improved cardiac function, 6,7 the effect of weight loss on cardiac function in a general population has not been fully investigated. Although our study design did not show a causal relation between body weight change and change in LV diastolic function, we demonstrated a significant association between changes in BMI and LV diastolic function based on serial measurements in a general population. It is plausible that preventive measures, such as weight control, may decrease the risk of LV diastolic dysfunction and prevent future clinical consequences.
Limitations
Several limitations of this study are acknowledged. First, the generalizability of our results might be limited, because we conducted our study at a single centre. Secondly, reverse causation may be an alternative interpretation. In other words, the individuals with improved LV diastolic function gained more exercise capacity so that they exercised more and lost weight. However, we assumed that improvement of LV diastolic function came after weight reduction, given the results of a randomized controlled trial 33 that demonstrated that weight reduction improved exercise capacity. Thirdly, possible selection bias of the study population might limit the interpretation. As participants themselves covered the expense for these imaging, the participants of the study might have higher consciousness towards their health than the general population. Fourthly, we did not have LVEF measurement by Simpson's methods. Although we exclude the participants with LV wall motion abnormalities, LVEF measurements by Simpson's methods is more ideal than measurement by Teichholz formula. The interpretation of E/E 0 might be overestimated, because there is a possible variability of E/E 0 between the measure on the medial annulus and lateral wall. Unfortunately, our database did not contain the measurement of E/E 0 on the lateral wall. Fifthly, dynamic variables such as BMI, medications, BP, and fasting glucose may change over time and could potentially influence the diastolic function. Since the primary goal of the proposed study was to understand the association between the changes in BMI and diastolic functions, we assume the influence of BMI consisted of both direct and indirect effect on diastolic function and did not include the other dynamic variables listed above. This assumption allows us to directly interpret the impact of BMI changes while avoiding additional model complexity. The causal relation between BMI and other dynamic variables warrants further investigation and is left to future work. Lastly, although we adjusted for the factors that affected LV diastolic function at the baseline visit, it is possible that there may have been other unknown or unmeasured influential factors that we did not adjust for in our analysis.
Conclusion
Our study showed that a change in BMI was associated with a change in LV diastolic function. The decrease in BMI that was observed from the first visit to the last visit corresponded to a significant decrease in LA volume index and a significant increase in E 0 velocity.
